US FDA: Johnson & Johnson's one-shot COVID-19 vaccine safe and effective in trials
|The one-shot COVID-19 vaccine developed by Johnson & Johnson appeared effective and safe in the latest trials, the US Food and Drug Administration (FDA) announced in a document published on Wednesday, as reported by Reuters.
"The FDA's panel of independent experts meets on Friday to decide whether to approve the shot," Reuters noted. "While it is not bound to follow the advice of its experts, the FDA did so when authorizing the Pfizer Inc and Moderna Inc vaccines."
Market reaction
The market mood remains upbeat following this headline and the S&P 500 Futures were last seen gaining 0.38% on the day at 3,892.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.